Viveon Health Acquisition... (VHAQ)
Viveon Health Acquisition Statistics
Share Statistics
Viveon Health Acquisition has - shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.83% |
| Shares Floating | 651.93K |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.09K, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 1.09K |
| Short % of Shares Out | 0.02% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 999.99 |
Valuation Ratios
The PE ratio is -267.44 and the forward PE ratio is null. Viveon Health Acquisition's PEG ratio is 1.91.
| PE Ratio | -267.44 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 39.05 |
| P/FCF Ratio | -74.25 |
| PEG Ratio | 1.91 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Viveon Health Acquisition.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 1.22.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | -2.32 |
| Interest Coverage | -0.65 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 61.31K |
| Effective Tax Rate | -14.41% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is -0.11, so Viveon Health Acquisition's price volatility has been lower than the market average.
| Beta | -0.11 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 10 |
| 200-Day Moving Average | 10 |
| Relative Strength Index (RSI) | 84.27 |
| Average Volume (20 Days) | - |
Income Statement
| Revenue | n/a |
| Gross Profit | -756.39K |
| Operating Income | -2.37M |
| Net Income | -486.79K |
| EBITDA | 1.95M |
| EBIT | 3.22M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 19.85K in cash and 4.08M in debt, giving a net cash position of -4.06M.
| Cash & Cash Equivalents | 19.85K |
| Total Debt | 4.08M |
| Net Cash | -4.06M |
| Retained Earnings | -16.08M |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -1.75M and capital expenditures 0, giving a free cash flow of -1.75M.
| Operating Cash Flow | -1.75M |
| Capital Expenditures | 0 |
| Free Cash Flow | -1.75M |
| FCF Per Share | -0.14 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VHAQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for VHAQ.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |